Form 8-K ACADIA PHARMACEUTICALS For: Oct 28
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/24/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
- One killed, three injured when man attacks Swedish school with sword
ACADIA Pharmaceuticals board member Daniel Soland resigns
November 3, 2025 4:26 PM ESTAcadia Pharmaceuticals Inc. (NASDAQ: ACAD) announced that Daniel B. Soland resigned from the company's board of directors, effective October 30. Soland also stepped down from his positions as member and chair of the Nominating and Corporate Governance Committee.
Soland notified the board of his... More
